Literature DB >> 15760417

Current status of kidney and pancreas transplantation in the United States, 1994-2003.

Gabriel M Danovitch1, David J Cohen, Matthew R Weir, Peter G Stock, William M Bennett, Laura L Christensen, Randall S Sung.   

Abstract

This article reviews the OPTN/SRTR data collected on kidney and pancreas transplantation during 2003 in the context of trends over the past decade. Overall, the transplant community continued to struggle to meet the increasing demand for kidney and pancreas transplantation. The number of new wait-listed kidney registrants under the age of 50 has remained relatively stable since 1994, but the number of new registrants aged 50 to 64 has doubled. However, there was only a 2.3% increase in the total number of kidney transplants performed in 2003. Expanded criteria donor kidneys made up 20% of all recovered kidneys and 16% of all transplants performed, compared with 15% in the prior year. In May 2003, new rules were implemented to promote equity in kidney organ allocation. These changes seem to have improved access for historically disadvantaged groups, though they have reduced the quality of HLA matching. The effects on long-term outcomes have yet to be measured. Although the majority of SPK recipients are white (82%), the percentage of simultaneous kidney-pancreas recipients who are African-American has increased from 9% in 2000 to 16% in 2003. The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period.

Entities:  

Mesh:

Year:  2005        PMID: 15760417     DOI: 10.1111/j.1600-6135.2005.00835.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  40 in total

1.  Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States.

Authors:  Jagbir Gill; Marcelo Sampaio; John S Gill; James Dong; Hung-Tien Kuo; Gabriel M Danovitch; Suphamai Bunnapradist
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Early outcomes among those initiating chronic dialysis in the United States.

Authors:  Kevin E Chan; Frank W Maddux; Nina Tolkoff-Rubin; S Ananth Karumanchi; Ravi Thadhani; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent cytomegalovirus infection.

Authors:  K Welzl; B Weinberger; A Kronbichler; G Sturm; G Kern; G Mayer; B Grubeck-Loebenstein; C Koppelstaetter
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

4.  Organ donation decision: comparison of donor and nondonor families.

Authors:  J R Rodrigue; D L Cornell; R J Howard
Journal:  Am J Transplant       Date:  2006-01       Impact factor: 8.086

Review 5.  Surgical aspects of human islet isolation.

Authors:  Tatsuya Kin; A M James Shapiro
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

6.  Understanding the relationship between knowledge and African Americans' donation decision-making.

Authors:  Kimberly R Jacob Arriola; Dana H Z Robinson; Jennie P Perryman; Nancy Thompson
Journal:  Patient Educ Couns       Date:  2007-11-07

7.  Understanding the role of clergy in African American organ and tissue donation decision-making.

Authors:  Kimberly R Jacob Arriola; Jennie P Perryman; Michelle A Doldren; Carmen M Warren; Dana H Z Robinson
Journal:  Ethn Health       Date:  2007-11       Impact factor: 2.772

Review 8.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

9.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

10.  Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates.

Authors:  Katy Trébern-Launay; Michèle Kessler; Sahar Bayat-Makoei; Anne-Hélène Quérard; Serge Briançon; Magali Giral; Yohann Foucher
Journal:  Eur J Epidemiol       Date:  2017-10-30       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.